STEVENSON, Wash., Dec. 5, 2011 (GLOBE NEWSWIRE) -- Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:ERGO.OB) announced today that it has obtained approval from the Financial Industry Regulatory Authority (FINRA) to change its trading symbol from "TNUS" to "ERGO" effective immediately. The symbol change is the first step of the Company's previously announced strategy to rebrand its corporate identity as it enters the emerging market for food science biotechnology and nutrigenomics.
On November 7th, TNS announced that it would seek shareholder approval at its upcoming annual stockholders meeting to change its name to Entia Biosciences, Inc. (Entia) and form a new subsidiary called Total Nutraceutical Solutions, Inc. that will continue to manufacture and market health and wellness products to consumers. Entia will focus on the institutional dietary supplementation market with its ErgoD2™ formulations, an optimized blend of the two powerful antioxidants Ergothioneine and Ergocalciferol (vitamin D2). ErgoD2™ is now being studied by Massachusetts General Hospital to assess its efficacy as a potential dietary therapy or palliative therapy for Parkinson's disease patients. Entia intends to announce additional collaborative research studies and clinical trials in the coming months that will address other potential applications for the Company's proprietary food-based technology and products. Commenting on this change, Dr. Marvin Hausman, CEO of TNS stated, "The market for our Ergo-based products is significant and we feel that using ERGO as our stock symbol will help to reinforce the brand and Entia's corporate identity as we move forward."
About Total Nutraceutical Solutions, Inc. and Entia Biosciences, Inc.
TNS is an emerging leader in whole food biotechnology that identifies, scientifically validates, and commercializes solutions that address multi-billion dollar markets for organic health, beauty and agriculture. The Company's growing portfolio of intellectual property includes extraction, enhancement, and uses for some of the most powerful antioxidants and bionutrients occurring in nature.
For more information, please visit our web sites at www.entiabio.com and www.totalnutraceuticals.com
The Total Nutraceutical Solutions, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8060
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc. with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2010 and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward- looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.